Literature DB >> 19349314

Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis.

Sagnik Bhattacharyya1, Paolo Fusar-Poli, Stefan Borgwardt, Rocio Martin-Santos, Chiara Nosarti, Colin O'Carroll, Paul Allen, Marc L Seal, Paul C Fletcher, José A Crippa, Vincent Giampietro, Andrea Mechelli, Zerrin Atakan, Philip McGuire.   

Abstract

CONTEXT: Cannabis sativa use can impair verbal learning, provoke acute psychosis, and increase the risk of schizophrenia. It is unclear where C. sativa acts in the human brain to modulate verbal learning and to induce psychotic symptoms.
OBJECTIVES: To investigate the effects of 2 main psychoactive constituents of C. sativa, Delta9-tetrahydrocannabinol (Delta9-THC) and cannabidiol, on regional brain function during verbal paired associate learning.
DESIGN: Subjects were studied on 3 separate occasions using a block design functional magnetic resonance imaging paradigm while performing a verbal paired associate learning task. Each imaging session was preceded by the ingestion of Delta9-THC (10 mg), cannabidiol (600 mg), or placebo in a double-blind, randomized, placebo-controlled, repeated-measures, within-subject design.
SETTING: University research center. PARTICIPANTS: Fifteen healthy, native English-speaking, right-handed men of white race/ethnicity who had used C. sativa 15 times or less and had minimal exposure to other illicit drugs in their lifetime. MAIN OUTCOME MEASURES: Regional brain activation (blood oxygen level-dependent response), performance in a verbal learning task, and objective and subjective ratings of psychotic symptoms, anxiety, intoxication, and sedation.
RESULTS: Delta9-Tetrahydrocannabinol increased psychotic symptoms and levels of anxiety, intoxication, and sedation, whereas no significant effect was noted on these parameters following administration of cannabidiol. Performance in the verbal learning task was not significantly modulated by either drug. Administration of Delta9-THC augmented activation in the parahippocampal gyrus during blocks 2 and 3 such that the normal linear decrement in activation across repeated encoding blocks was no longer evident. Delta9-Tetrahydrocannabinol also attenuated the normal time-dependent change in ventrostriatal activation during retrieval of word pairs, which was directly correlated with concurrently induced psychotic symptoms. In contrast, administration of cannabidiol had no such effect.
CONCLUSION: The modulation of mediotemporal and ventrostriatal function by Delta9-THC may underlie the effects of C. sativa on verbal learning and psychotic symptoms, respectively.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19349314     DOI: 10.1001/archgenpsychiatry.2009.17

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  89 in total

1.  Hippocampal volume reduction specific for later transition to psychosis or substance-associated effects?

Authors:  Stefan Borgwardt; Renata Smieskova; Kerstin Bendfeldt; Eva Bühlmann; Gregor Berger; Jacqueline Aston; Ute Gschwandtner; Marlon Pflueger; Rolf-Dieter Stieglitz; Anita Riecher-Rössler; Ernst-Wilhelm Radue
Journal:  J Psychiatry Neurosci       Date:  2010-05       Impact factor: 6.186

2.  Cannabis, a complex plant: different compounds and different effects on individuals.

Authors:  Zerrin Atakan
Journal:  Ther Adv Psychopharmacol       Date:  2012-12

3.  One Month of Cannabis Abstinence in Adolescents and Young Adults Is Associated With Improved Memory.

Authors:  Randi Melissa Schuster; Jodi Gilman; David Schoenfeld; John Evenden; Maya Hareli; Christine Ulysse; Emily Nip; Ailish Hanly; Haiyue Zhang; A Eden Evins
Journal:  J Clin Psychiatry       Date:  2018-10-30       Impact factor: 4.384

4.  Δ-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors.

Authors:  Hanna J Szkudlarek; Sagar J Desai; Justine Renard; Brian Pereira; Christopher Norris; Christina E L Jobson; Nagalingam Rajakumar; Brian L Allman; Steven R Laviolette
Journal:  Neuropsychopharmacology       Date:  2018-11-27       Impact factor: 7.853

5.  Temporal Changes in the Cross-Sectional Associations between Cannabis Use, Suicidal Ideation, and Depression in a Nationally Representative Sample of Canadian Adults in 2012 Compared to 2002.

Authors:  Jillian E Halladay; Catharine Munn; Michael Boyle; Susan M Jack; Katholiki Georgiades
Journal:  Can J Psychiatry       Date:  2019-06-09       Impact factor: 4.356

Review 6.  The why behind the high: determinants of neurocognition during acute cannabis exposure.

Authors:  Johannes G Ramaekers; Natasha L Mason; Lilian Kloft; Eef L Theunissen
Journal:  Nat Rev Neurosci       Date:  2021-05-27       Impact factor: 34.870

7.  Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.

Authors:  Nicholas A Jones; Andrew J Hill; Imogen Smith; Sarah A Bevan; Claire M Williams; Benjamin J Whalley; Gary J Stephens
Journal:  J Pharmacol Exp Ther       Date:  2009-11-11       Impact factor: 4.030

Review 8.  A key role of the basal ganglia in pain and analgesia--insights gained through human functional imaging.

Authors:  David Borsook; Jaymin Upadhyay; Eric H Chudler; Lino Becerra
Journal:  Mol Pain       Date:  2010-05-13       Impact factor: 3.395

9.  Rivastigmine but not vardenafil reverses cannabis-induced impairment of verbal memory in healthy humans.

Authors:  E L Theunissen; P Heckman; E B de Sousa Fernandes Perna; K P C Kuypers; A Sambeth; A Blokland; J Prickaerts; S W Toennes; J G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2014-07-08       Impact factor: 4.530

10.  Should burden of disease estimates include cannabis use as a risk factor for psychosis?

Authors:  Louisa Degenhardt; Wayne D Hall; Michael Lynskey; John McGrath; Jennifer McLaren; Bianca Calabria; Harvey Whiteford; Theo Vos
Journal:  PLoS Med       Date:  2009-09-29       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.